MedPath

Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term

Not Applicable
Completed
Conditions
Growth
Interventions
Other: Extensively hydrolyzed infant formula
Registration Number
NCT00936637
Lead Sponsor
Perrigo Nutritionals
Brief Summary

The purpose of this study is to assess growth in infants who are fed an extensively hydrolyzed formula.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • At birth:

    • Healthy, term (37-42 weeks) infant
    • Weight for length between the 10th and 90th percentile according to the National Center for Health Statistics (NCHS) growth charts
  • At time of enrollment:

    • < or = 21 days post-natal age
    • Weight for length between the 10th and 90th percentile according to the National Center for Health Statistics (NCHS) growth charts
    • Exclusively formula fed
    • Written informed consent of parent/guardian
Exclusion Criteria
  • At the time of enrollment: partially human-milk fed; fed baby/solid foods
  • Conditions requiring feedings other than those specified in the protocol
  • Documented or suspected cow's milk allergy and/or soy protein allergies
  • Major congenital deformities
  • Suspected or documented systemic or congenital infections
  • Evidence of cardiac, respiratory, hematological, gastrointestinal, or other systemic diseases
  • Participation in any other clinical trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Extensively hydrolyzed infant formulaExtensively hydrolyzed infant formula-
Primary Outcome Measures
NameTimeMethod
An extensively hydrolyzed formula is nutritionally adequate for normal growth of healthy full-term infants16 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Virginia

🇺🇸

Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath